BioCentury
ARTICLE | Clinical News

Jext regulatory update

October 18, 2010 7:00 AM UTC

ALK-Abello said its Jext adrenaline auto-injector pen was approved in 17 European countries for the emergency treatment of severe acute allergic reactions. The company expects to begin launching the p...